Category: Finance
High Voltage: Lithium market recovery narrative picks up. Perfect storm brewing?
What’s shaking in the land of the lithium lizards? (And other battery metals.) Let’s see… Is there something of a perfect storm forming for [more…]
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 1
It’s been a tough couple of years for ASX health care with challenging economic conditions including steep interest rates rises to combat soaring inflation hitting [more…]
Q3 earnings showed ASX resilience, but these three companies were remarkable: Tru Datt!
Welcome to Tru Datt, a Stockhead exclusive featuring the insights and opportunities as per Emanuel Datt – founder and chief investment officer at Datt Capital [more…]
Rise and Shine: Everything you need to know before the ASX opens
On Stockhead today, is that a PERFECT LITHIUM STORM on the horizon? Three remarkable companies, according to Emanuel Datt, and there’s no better time to [more…]
Ken Griffin Warns Against Premature Rate Cuts Amid Inflation Concerns
In a recent statement at the International Futures Industry conference in Boca Raton, Florida, Ken Griffin, the founder and CEO of Citadel, advised caution against [more…]
Welchau could propel ADX into the big leagues, but it is not the only dish the company is serving up
ADX Energy is ramping up activity as it progresses the next stage of its development Work is underway to boost both its cash flow and [more…]
Monsters of Rock: Liontown back in business with $550m debt facility
Liontown Resources shares surge after Kathleen Valley owner nabs $550m debt package Core Lithium sinks after CEO exit and big half year loss Jupiter [more…]
Closing Bell: ASX ends higher but iron’s ordinary problem isn’t going away
Local markets give up early gains then regains them, closing 0.22pc higher Consumer Discretionary stocks offset losses in materials and Energy Small Caps led [more…]
Haranga Resources is eyeing a uranium resource upgrade at Saraya
RC drilling returns shallow, uranium mineralisation at Saraya pXRF analysis shows widths and concentrations that are consistent with Haranga’s mineralisation model Assays sent to the [more…]
Neurotech extends clinical trials for the $US2bn Rett Syndrome market
12-week Phase I/II clinical trial to treat Rett Syndrome with NTI164 broad spectrum cannabinoid drug therapy extended to 52 weeks All 14 female patients to [more…]
